Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer
about
Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependentSerum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas.Prognostic significance of CD26 in patients with colorectal cancerColorectal cancer: from prevention to personalized medicine.Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients.A novel multiplex-protein array for serum diagnostics of colon cancer: a case-control studyInhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes.Clinical significance of soluble CD26 in malignant pleural mesothelioma.Potential of soluble CD26 as a serum marker for colorectal cancer detection.Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.Dipeptidyl-peptidase IV activity is correlated with colorectal cancer prognosis.In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery.Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test.Altered Activity and Expression of Cytosolic Peptidases in Colorectal CancerPopulation Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus.Serum CD26 levels in patients with gastric cancer: a novel potential diagnostic marker.Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening.Dipeptidyl peptidase 4 promotes epithelial cell transformation and breast tumourigenesis via induction of PIN1 gene expression.Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma.Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug.Dipeptidyl peptidase IV is a human and murine neutrophil chemorepellentEarly detection of colon cancer: new tests on the horizon.Prolyl endopeptidase activity is correlated with colorectal cancer prognosis.Dipeptidyl peptidase-IV and related molecules: markers of malignancy?Small-Molecule Compounds Exhibiting Target-Mediated Drug Disposition (TMDD): A Minireview.Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein.Aminopeptidase N activity predicts 5-year survival in colorectal cancer patients.Impact of target-mediated drug disposition on Linagliptin pharmacokinetics and DPP-4 inhibition in type 2 diabetic patients.Concentration-dependent plasma protein binding of the novel dipeptidyl peptidase 4 inhibitor BI 1356 due to saturable binding to its target in plasma of mice, rats and humans.
P2860
Q33575499-DA7AB933-B7C8-4A0C-8252-FD13242E9C36Q33618421-D6ECAABA-CBCC-4D07-A36D-FECCBA449456Q33679546-CD6E0B8D-D892-46A9-944F-C061524C058CQ33735234-466F0658-9BC9-4A5D-915F-E474F4F465AAQ34166374-A54BEC14-8DB7-4C38-9D7F-86F74F8E4FBEQ34407192-A1777355-4FAC-4110-90DF-013B28C6D8E8Q34468372-27B0DDD0-77AF-425A-BF48-395798DEB1F3Q34648201-25746B8C-5ADD-424A-9739-A41A11BDADACQ34744092-4C021363-7B08-4B80-A038-A10040D1DED0Q35113393-F4DDB7BF-4C07-4A77-BAD4-3F80E90BC16BQ35189265-810E3515-F52D-4362-AAD7-6B466EF6BB51Q35195876-9A8B7259-5647-4A42-B1EC-C35BB2018052Q35325715-47E6826A-145C-4D40-8CAD-609967966C01Q35677316-2842CFE8-01FE-450D-BE76-12010A4CCE6EQ35739764-F36A7F63-EDBD-4F02-B5D8-7B89B6FC5CA4Q35800419-219D86E6-06C0-493F-B14E-91F74594F7F2Q35809359-6F34282E-CB17-487A-9FFA-E5119F796BB8Q35889928-30C71F15-AB0F-4E11-9901-8F5EDB050E4FQ36395003-6B7E9E58-4032-456D-9731-69D59E747B2FQ36609565-AC2C9092-E5B3-464E-B03B-17C6C63E1CEFQ36735761-46EA0B2A-F1A4-4DED-9A65-ADEA535D1E12Q37130392-D82C142B-B878-4863-A427-715476F759BEQ37141998-82D3A817-B363-4A74-93E3-2E5D312ADB0EQ37488703-53E54911-E243-41B8-943F-F38743E5F082Q38089765-F27F4B4A-621D-41C0-992B-3348093F75C1Q38917756-5F06F302-66FB-40ED-BA79-23F37117F9B8Q39377477-7E0FEA0F-FBDE-4940-AE3E-BC56E9734B82Q40992354-84658363-3408-44ED-9E13-09001FDDE0B5Q43160186-466545F9-BA8B-4091-9E3A-B649C69CC92FQ46173560-241CCFBD-5527-4F33-8171-71D50137272B
P2860
Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Preoperative serum CD26 levels ...... ve value for colorectal cancer
@ast
Preoperative serum CD26 levels ...... ve value for colorectal cancer
@en
type
label
Preoperative serum CD26 levels ...... ve value for colorectal cancer
@ast
Preoperative serum CD26 levels ...... ve value for colorectal cancer
@en
prefLabel
Preoperative serum CD26 levels ...... ve value for colorectal cancer
@ast
Preoperative serum CD26 levels ...... ve value for colorectal cancer
@en
P2093
P2860
P356
P1476
Preoperative serum CD26 levels ...... ve value for colorectal cancer
@en
P2093
Cordero OJ
Nogueira M
Rodriguez-Berrocal FJ
de la Cadena MP
P2860
P2888
P304
P356
10.1054/BJOC.2000.1410
P407
P577
2000-11-01T00:00:00Z
P5875
P6179
1036411757